top of page

EU Notified Bodies are lagging in MDR designation

Writer: Robert Bilkovski, MD
Robert Bilkovski, MD
Dec 21, 2019
1 min read

With the implementation date of EU MDR fast approaching (2020) for all Class 1-3 devices, notified bodies are having a difficult time meeting and receiving MDR designation status. The European Union projected that 20 notified bodies would become MDR designated by 2020, but only eight have been designated to date.


Class 1 devices often carry markedly reduced risk (i.e. tongue depressors are Class 1). Given their lower risk and suboptimal number of notified bodies being ready for MDR implementation, the EU has implemented a 4-year delay for some Class 1 devices.


This decision by the European Union while alleviating stress upon Class 1 device manufactures, allows notified bodies to focus their efforts on higher risk Class 2 (a and b) and 3 devices.



To learn more about the MDR remediation services offered by RNB Ventures Consulting, please contact the author at robert@RNBVenturesConsulting.com


 
 
 

Comments


MedTech

Medical device and IVD companies preparing for launch or scale

Pharma/Biotech

Pharma/biotech teams supporting evidence-based education

Startups

Startups needing investor-ready clinical narratives without hype

Customer Education

Programs facing internal MLR/AdPromo friction

Organizations needing credible physician-facing education

Built for Teams Under Real Scrutiny

© 2025 by RNB Ventures Consulting, Inc.

    • LinkedIn Social Icon
    bottom of page